|
Volumn 15, Issue 7, 2008, Pages 429-435
|
Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets
|
Author keywords
Bioavailability; Dextromethorphan Hydrobromide; Hydrophilic matrices; Sustained release
|
Indexed keywords
AEROSIL;
CARBOMER;
DEXTROMETHORPHAN;
HYDROXYPROPYLMETHYLCELLULOSE;
MAGNESIUM STEARATE;
METHYLCELLULOSE;
MICROCRYSTALLINE CELLULOSE;
POVIDONE;
POVIDONE IODINE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG GRANULE;
DRUG HALF LIFE;
DRUG RELEASE;
DRUG SOLUBILITY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
HYDROPHILICITY;
IN VITRO STUDY;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
SUSTAINED DRUG RELEASE;
TABLET;
TIME TO MAXIMUM PLASMA CONCENTRATION;
VOLUNTEER;
ADULT;
ANTITUSSIVE AGENTS;
BIOLOGICAL AVAILABILITY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CROSS-OVER STUDIES;
DELAYED-ACTION PREPARATIONS;
DEXTROMETHORPHAN;
DRUG COMPOUNDING;
DRUG STABILITY;
EXCIPIENTS;
HUMANS;
KINETICS;
MALE;
METHYLCELLULOSE;
TABLETS;
|
EID: 49949096129
PISSN: 10717544
EISSN: 15210464
Source Type: Journal
DOI: 10.1080/10717540802035301 Document Type: Article |
Times cited : (16)
|
References (12)
|